THE LEVEL OF A NUMBER OF MARKERS OF MYOCARDIAL DYSFUNCTION IN BLOOD PLASMA IN CASE OF ANTHRACYCLINE-MEDIATED CARDIOTOXICITY IN CANCER PATIENTS